Our results demonstrated that cancer-derived IgG silencing inhibited the phosphorylation levels of MAPK (ERK, JNK, and p38), IKKα/β, IκBα, and NF-κB subunit p65 in cervical cancer cells. This evidence concerns the gene NFKB1 and cervical carcinoma.